SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Ask Michael Burke -- Ignore unavailable to you. Want to Upgrade?

To: Martin A. Helfand who wrote (49919)3/5/1999 2:01:00 PM
From: Knighty Tin  Respond to of 132070
 
Martin, Basically, Genzyme the parent has drugs being sold and earnings being made and is a blue chip in the sector. The two kids are basically research shells working on, IMHO, very exciting new products and techniques, but not yet selling diddly squat and in constant need of cash. I think the potential is much greater for the research subs, but the safety is with the parent. My conclusion is, who buys biotech for safety? <g>

MB


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News